Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot

March 22, 2025 updated by: Busra Sirin, Beylikduzu State Hospital

Greek vs. Egyptian Foot: The Impact of Second Toe Length on Hallux Valgus Development

A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded. The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beylikdüzü
      • Istanbul, Beylikdüzü, Turkey, 34147
        • Recruiting
        • Beylikduzu State Hospital
        • Principal Investigator:
          • Büşra Şirin Ahısha, MD
        • Contact:
        • Sub-Investigator:
          • Nurdan Paker, Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

The study population will consist of 150 patients aged 60-80 years who have existing foot radiographs suitable for measurement.

Description

Inclusion Criteria:

  • Age between 60-80 years
  • Presence of foot radiographs suitable for measurement
  • No history of prior foot surgery

Exclusion Criteria:

  • History of foot trauma or fractures
  • Previous foot or toe surgery
  • Presence of congenital foot deformities
  • Neurological or rheumatologic conditions affecting foot structure
  • Severe osteoarthritis or other degenerative foot diseases visible on radiographs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hallux Valgus Angle
Time Frame: 0 day
The angle between the first metatarsal and the proximal phalanx of the first toe, measured on radiographs. Higher values indicate greater hallux valgus severity.
0 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Intermetatarsal Angle
Time Frame: 0 day
The angle between the first and second metatarsal bones, measured on radiographs. Higher values are associated with increased deformity.
0 day
First Toe (Hallux) Metatarsal and Phalanx Lengths
Time Frame: 0 day
The length of the first metatarsal and its phalanges, measured on radiographs.
0 day
Second Toe Metatarsal and Phalanx Lengths
Time Frame: 0 day
The length of the second metatarsal and its phalanges, measured on radiographs.
0 day
Second Toe to First Toe Phalanx Length Ratio
Time Frame: 0 day
The ratio of the second toe phalanx length to the first toe phalanx length, calculated to assess relative toe length differences.
0 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2025

Primary Completion (Estimated)

April 10, 2025

Study Completion (Estimated)

April 10, 2025

Study Registration Dates

First Submitted

March 8, 2025

First Submitted That Met QC Criteria

March 8, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Estimated)

March 26, 2025

Last Update Submitted That Met QC Criteria

March 22, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • BeylikduzuStateH15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe